Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Weed (BUDZ) EBITDA (2017 - 2025)

Weed has reported EBITDA over the past 12 years, most recently at -$750184.0 for Q4 2025.

  • For Q4 2025, EBITDA fell 470.56% year-over-year to -$750184.0; the TTM value through Dec 2025 reached -$1.4 million, down 168.87%, while the annual FY2025 figure was -$1.4 million, 168.87% down from the prior year.
  • EBITDA for Q4 2025 was -$750184.0 at Weed, down from -$73949.0 in the prior quarter.
  • Over five years, EBITDA peaked at $735612.0 in Q3 2023 and troughed at -$1.2 million in Q2 2021.
  • A 5-year average of -$305790.9 and a median of -$174237.0 in 2021 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: surged 338.58% in 2023 and later tumbled 470.56% in 2025.
  • Year by year, EBITDA stood at -$174237.0 in 2021, then crashed by 392.11% to -$857431.0 in 2022, then surged by 54.08% to -$393756.0 in 2023, then soared by 66.61% to -$131481.0 in 2024, then tumbled by 470.56% to -$750184.0 in 2025.
  • Business Quant data shows EBITDA for BUDZ at -$750184.0 in Q4 2025, -$73949.0 in Q3 2025, and -$106504.0 in Q2 2025.